(Q37767725)

22 August 2017

1 reference

title

Coeliac disease--a diagnostic and therapeutic challenge (English)

1 reference

22 August 2017

0 references

5

Markku Mäki

1 reference

22 August 2017

3

Pekka Collin

1 reference

22 August 2017

4

Outi Koskinen

1 reference

22 August 2017

1

Katri Kaukinen

1 reference

22 August 2017

Katri Lindfors

2

1 reference

22 August 2017

publication date

1 September 2010

1 reference

Clinical Chemistry and Laboratory Medicine

22 August 2017

published in

1 reference

22 August 2017

volume

48

1 reference

22 August 2017

issue

9

1 reference

22 August 2017

page(s)

1205-1216

1 reference

Management of infantile gastroenteritis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Trends in the presentation of celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Diagnosis of celiac disease in clinical practice: physician's alertness to the condition essential

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Intolerance to cereals is not specific for coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Anemia in celiac disease is multifactorial in etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac disease in autoimmune cholestatic liver disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Prevalence of Celiac disease among children in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Mass screening for coeliac disease using antihuman transglutaminase antibody assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Predictors of family risk for celiac disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

High frequency of coeliac disease in adult patients with type-I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Endocrinological disorders and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac disease in children and adolescents with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

High prevalence of celiac sprue among patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac disease and alopecia areata: report of a new association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Prevalence of coeliac disease in patients with sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

The diagnostic accuracy of serologic tests for celiac disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac disease screening by immunochromatographic visual assays: results of a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Adult celiac disease and the severe "flat" small bowel biopsy lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Variability of histopathological changes in childhood celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Latent coeliac disease or coeliac disease beyond villous atrophy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

The first large population based twin study of coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Concordance, disease progression, and heritability of coeliac disease in Italian twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Newly identified genetic risk variants for celiac disease related to the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Adaptive and innate immune responses in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Angiogenesis as a novel component of inflammatory bowel disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Increased prevalence and mortality in undiagnosed celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Why is coeliac disease endemic in the people of the Sahara?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Children born in the summer have increased risk for coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Malignancy in coeliac disease--effect of a gluten free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Living with coeliac disease: controlled study of the burden of illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

No harm from five year ingestion of oats in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Oats in the treatment of childhood coeliac disease: a 2-year controlled trial and a long-term clinical follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Oats to children with newly diagnosed coeliac disease: a randomised double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

The molecular basis for oat intolerance in patients with celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Etiologies and predictors of diagnosis in nonresponsive celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac Disease and Risk of Liver Disease: A General Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Prevalence and Clinical Picture of Celiac Disease in Italian Down Syndrome Patients: A Multicenter Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Lower economic status and inferior hygienic environment may protect against celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

Mortality in patients with coeliac disease and their relatives: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2010.241

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.241

1 reference

22 August 2017

1 reference